Table 1 (abstract O02). See text for description
From: Proceedings of the 28th European Paediatric Rheumatology Congress (PReS 2022)
Parameter | Arthritis (n=177) | Data available | No arthritis (n=85) | Data available | P value |
|---|---|---|---|---|---|
Age at diagnosis, median (IQR) yrs | 5.0 (2.8-9.3) | 177 | 7.8 (3.9-12.5) | 85 | <0.01* |
Duration of follow-up, median (IQR) yrs | 5.2 (2.1-9.5) | 177 | 2.4 (1.0-5.1) | 85 | <0.0001* |
Number of visits, median (IQR) | 16 (8-29) | 177 | 9 (5-17) | 85 | 0.0001* |
Rash at baseline, n (%) | 119 (77%)§ | 155 | 75 (100%)§ | 75 | <0.0001†§ |
Serositis at baseline, n (%) | 17 (13%)§ | 133 | 16 (24%)§ | 68 | 0.05†§ |
(Hepato) splenomegaly at baseline, n (%) | 33 (19%)§ | 146 | 26 (31%)§ | 73 | 0.04†§ |